Engvangin nge Coriolus versicolor powder hi ‘nature’s master immune modulator’ tia koh a nih? A dual anticancer leh liver-protective mechanisms te scientific analysis hmanga zirchian a ni.

A rilru a buai em em a, a rilru a hah em em bawk.

Coriolus versicolor powder hi he damdawi chi khat, a rah chhuah, a rah chhuah (fruiting body) atanga lak chhuah a ni. modern research chuan unique 1000 a pai tih a tarlang.Polysaccharide peptides (PSP) a ni a, a man pawh a to hle.lehPolysaccharides (PSK) 1000 a ni.Complex hrang hrang a awm. Engtin nge heng active components te hian multi-target mechanism hmangin "cancer guardian" leh "liver protector" pahnih atan an thawk thei ang?

Core active components leh mechanism te .

Polysaccharide peptide (PSP) a ni a, a man pawh a to hle.

Immune Sentinel activation a ni.: Dendritic cell puitlin 3× leh antigen presentation efficiency 50% in a tipung

Anticancer Synergy 1000 a ni.: PD-1 inhibitor effects a tichak (tumor shrinkage rate 35% a sang)

Radiation laka invenna .: Post a tihtlem-Radiotherapy lymphocyte apoptosis (60% venhimna rate)

Polysaccharide (PSK) 1000 a ni.

Direct tumor a inhi theihna tur a ni.: Tumor cell MMP-2/9 secretion a titawp (70% in metastatic potential a tihhniam)

Hepatocyte siam thar lehna tur a ni.: Liver growth factor secretion a tichak (40% a pung chak zawk)

Antiviral hmanga invenna .: HIV virus binding chu CD4 receptor-ah a block (IC50=12ug/ml)

TRITERPENOIDS 1000 a ni.

Chemo-Detoxification .: Cisplatin-induced kidney a ti tlem (serum creatinine a tlahniam)

Bile Optimization 1000 a ni.: Bile acid components \\angkai tak tak a tipung (2× UDCA a tam zawk)

Mitochondrial laka invenna .: Hypoxia hnuaiah 80% hepatocyte ATP level a enkawl

Clinically validated benefits .

Cancer adjunctive hmanga enkawlna .

Gastric cancer-ah hian thla 8.5-in a dam rei zawng a tizau a (Phase III trial)

55% in radiation a tihhniam-induced oral mucositis

Liver natna enkawl dan .

2-3LOg HBV DNA viral load a tlahniam (kar 48 chhung)

35% chuan zu ruih theihna tur liver fibrosis score-ah 35% zetin hma an sawn a ni.

Immune reconstitution 1000 a ni.

60% a chak zawk CD4+ Cell Recovery Post-Chemotherapy

Bone marrow transplant hnua infection rate 40% a tlahniam

Chronic inflammation .

Ulcerative colitis-a remission rate 68% a ni.

Rheumatoid factor 25% in a tlahniam a ni.

Precision hman dan tur protocol .

Scientific combination hmanga thil tih dan tur .

selenium nen .: Glutathione peroxidase (GPX) hnathawh chu 30% in a tichak a ni.

Boswellia extract nen .: Dual NF-κB/Cox-2 inhibition (2.3× anti-inflammatory effect)

Probiotics nen .: Chemo-related diarrhea (50% a thawh that zawk) a ti tha zawk.

Fimkhurna bik .

⚠ Therapeutic window effect a awm em?: 5g/day aia tam chuan immunosuppression a thlen thei (enkawlna a ngai)
⚠ Surgical tih dan tur .: Kar 2 chhung hun hman chhunzawm loh pre-op (Bleeding Risk)
⚠ Autoimmune natna te .: Close immune monitoring a mamawh a ni .

Rangkachak quality tha tak tak te .

1 Thlai chi hrang hrang lakchhuah (mycelium ni lo) .
2 Dual-Fermentation Technology (PSP/PSK Balance)
3 Heavy metal test (PB<0.5ppm)

User testimonial te .

"Liver cancer intervention therapy hnua AFP level nghet tak" - 52M (a hman dan pangngai nen)
"Chronic HBV carrier chuan a tawpah seroclearance a hmu ta" - 38F (antivirals nena inzawm)

Mechanistic lama hmasawnna te .

Immune checkpoint modulation 1000 a ni.(2023-a thil hmuhchhuah):

Tumor a tipung-Cd8+ T cells (2.3×) a tisang a.

Treg proportion (25%→12%) a tihtlem.

Gut-Liver Axis Regulation .:

Butyrate a tichak-Bacteria siam chhuahna (Faecalibacterium 3.5×)

Endotoxin level a tihniam (42%).

Eng thilin nge Coriolus hi a danglam bik?
Single-component anticancer drugs nen khaikhin chuan:

Dual immune modulation leh direct antitumor action .

Organ venhimna leh therapeutic enhancement te a inzawm chuan .

"Fu Zheng Qu Xie" tih ngaihdan hi tunlai khawvela tihdikna a ni.